Clinical Trial Update: NBTXR3 Crystalline Nanoparticles and Radiation Therapy in Treating Randomized Patients in Two Arms With Soft Tissue Sarcoma of the Extremity and Trunk Wall [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial evaluating NBTXR3 crystalline nanoparticles with radiation therapy in adults with soft tissue sarcoma of the extremity and trunk wall has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• NBTXR3 (hafnium oxide nanoparticles)

Snippet

Sponsor: Nanobiotix | Conditions: Adult Soft Tissue Sarcoma | Phase 2, Phase 3 | Status: COMPLETED